The Stem Cell Blog – Page 200

Chardan’s Top Pick For 2018: Gene Therapy Firm Uniqure – Benzinga

2018-04-24 Michael Zand NEWS

CRISPR Screens Stem Cell Genome, Charts Essentialome – Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology NewsCRISPR Screens Stem Cell Genome, Charts EssentialomeGenetic Engineering & Biotechnology NewsScientists at the Hebrew University of Jerusalem have generated an atlas of genes—the essentialome —that are essential f… Continue reading

2018-04-24 Michael Zand NEWS

US Stem Cell (OTCMKTS:USRM) Issues Earnings Results – The Ledger Gazette

The Ledger GazetteUS Stem Cell (OTCMKTS:USRM) Issues Earnings ResultsThe Ledger GazetteU.S. Stem Cell (OTCMKTS:USRM) posted its earnings results on Monday, April 16th. The company reported $0.05 earnings per share for the quarter, Bloomberg Earnings re… Continue reading

2018-04-24 Michael Zand NEWS

CTG Catapult opens its new unique cell and gene therapy plant in the UK – FiercePharma

FiercePharmaCTG Catapult opens its new unique cell and gene therapy plant in the UKFiercePharmaThe launch of this important facility pushes the agenda forward and accelerates the timeframe for bringing these living medicines to patients.” Initial partn… Continue reading

2018-04-24 Michael Zand NEWS

CTG Catapult opens its new unique cell and gene therapy plant in the UK – FiercePharma

2018-04-24 Michael Zand NEWS

Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales – PR Newswire (press release)

PR Newswire (press release)Market Demand for Stem Cell Treatments Driving Steady Increase in USRM SalesPR Newswire (press release)"Our increase in patients is providing us with an opportunity to serve the needs of more and more patients who had gi… Continue reading

2018-04-24 Michael Zand NEWS

Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales – PR Newswire (press release)

2018-04-24 Michael Zand NEWS

CAR T-cell Therapy at Higher Dose Might Treat Advanced Neuroblastoma, Early Trial Results Suggest – Immuno-Oncology News

Immuno-Oncology NewsCAR T-cell Therapy at Higher Dose Might Treat Advanced Neuroblastoma, Early Trial Results SuggestImmuno-Oncology NewsIn this first clinical study in patients (NCT02761915), researchers are investigating the safety and the potential … Continue reading

2018-04-24 Michael Zand NEWS

1
…
198
199
200
201
202
…
2,487

Benzinga

Chardan’s Top Pick For 2018: Gene Therapy Firm Uniqure
Benzinga
Amusa expects uniQure, with a scaled manufacturing process, to beat Spark Therapeutics Inc (NASDAQ: ONCE) to market with its AAV-based hemophilia B gene therapy. Hemophilia B presents a market opportunity north of $15 billion, and Amusa anticipates a …

and more »

Login

Cart

Tag Archives: The Stem Cell Blog

Chardan’s Top Pick For 2018: Gene Therapy Firm Uniqure – Benzinga

CRISPR Screens Stem Cell Genome, Charts Essentialome – Genetic Engineering & Biotechnology News

US Stem Cell (OTCMKTS:USRM) Issues Earnings Results – The Ledger Gazette

CTG Catapult opens its new unique cell and gene therapy plant in the UK – FiercePharma

CTG Catapult opens its new unique cell and gene therapy plant in the UK – FiercePharma

Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales – PR Newswire (press release)

Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales – PR Newswire (press release)

CAR T-cell Therapy at Higher Dose Might Treat Advanced Neuroblastoma, Early Trial Results Suggest – Immuno-Oncology News